These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [cGMP synthesis induced by atrial natriuretic peptide, C-type natriuretic peptide, and nitric oxide in the rat retina].
    Author: Moriwaki Y, Kamisaki Y, Itoh T.
    Journal: Nippon Ganka Gakkai Zasshi; 1996 Mar; 100(3):187-91. PubMed ID: 8900582.
    Abstract:
    This study was undertaken to determine whether atrial natriuretic peptide (ANP)-, C-type natriuretic peptide (CNP)-, and nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathways exist in the rat retina. Exposure of the retina to ANP (10(-7)M), CNP (10(-7)M), S-nitroso-N-acetylpenicillamine (10(-5)M, SNAP; a NO doner), A23187 (10(-5)M; a Ca2+ionophore), and carbachol (10(-5)M) caused 1.45-1.67 fold increases in cGMP content (p < 0.01). Carboxy-PTIO (10(-3)M; a NO scavanger) blocked the increase in cGMP induced by A23187. Both carboxy-PTIO (10(-3)M) and NG-nitro-L-arginine (10(-3)M, L-NNA; a NO inhibitor) blocked the increase in cGMP induced by carbachol. Atropine (10(-5)M; a muscarinic receptor antagonist) also blocked the cGMP increase induced by carbachol. These data demonstrate that ANP-, CNP- and NO-cGMP pathways exist in the retina and that the NO-cGMP pathway may be linked to the activation of the muscarinic receptor.
    [Abstract] [Full Text] [Related] [New Search]